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Abstract
Enantioselective catalytic allylic alkylation for the synthesis of 2-alkyl-2-allylcycloalkanones and 
3,3-disubstituted pyrrolidinones, piperidinones and piperazinones has been previously reported by 
our laboratory. The efficient construction of chiral all-carbon quaternary centers by allylic 
alkylation was previously achieved with a catalyst derived in situ from zero valent palladium 
sources and chiral phosphinooxazoline (PHOX) ligands. We now report an improved reaction 
protocol with broad applicability among different substrate classes in industry-compatible reaction 
media using loadings of palladium(II) acetate as low as 0.075 mol % and the readily available 
chiral PHOX ligands. The novel and highly efficient procedure enables facile scale-up of the 
reaction in an economical and sustainable fashion.
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The catalytic enantioselective construction of all-carbon quaternary centers represents a 
considerable challenge in synthetic organic chemistry.[1,2] A new carbon–carbon bond must 
be formed in the face of significant steric hindrance to accomplish this goal.
Synthetic methods for the generation of quaternary stereocenters are extremely desirable 
given their prevalence in a broad variety of biologically active natural products.[2] Despite 
their importance, the number of highly enantioselective transformations that construct 
quaternary stereocenters under mild reaction conditions is limited. The palladium-catalyzed 
decarboxylative asymmetric allylic alkylation is a powerful and reliable approach to bridge 
this gap.[3]
This class of reactions was developed in the 1980s by Tsuji and co-workers, employing 
various substrates, such as allyl enol carbonates[4] or β-ketoesters.[5] Over the past decade 
our group has made significant contributions to this field; our initial efforts resulted in the 
first catalytic enantioselective Tsuji allylic alkylation of simple alkanone derivatives in 
2004.[6] We have since expanded the scope of this transformation considerably,[7] and 
elucidated the catalytic cycle through mechanistic investigations.[8] Numerous applications 
of this technology in the field of natural product synthesis have been demonstrated by our 
group[9] and others,[10] highlighting the power and broad applicability of this reaction.
Despite the importance of palladium-catalyzed decarboxylative asymmetric alkylation in 
total synthesis, its application on an industrial scale is hampered by the need for high 
catalyst loadings (5.0–10.0 mol %). The high cost of palladium significantly increases the 
cost of each reaction. Furthermore, high catalyst loadings also increase the risk of poisoning 
downstream chemistry or contaminating active pharmaceutical ingredients.[11]
These drawbacks have prevented application of the enantioselective allylic alkylation on a 
larger scale. The application of transition metal catalysis to industry-scale synthesis requires 
transformations that are safe, robust, cost-effective, and scalable.[12]
Consequently, there remains a significant need to develop new reaction protocols that 
employ lower catalyst concentrations and hence facilitate the scale-up of such 
transformations. Consequently, we began to question the existing protocols and 
reinvestigated critical reaction parameters such as the palladium source, catalyst loading, 
solvent and temperature, with respect to the scalability of our reaction and its compatibility 
with industry requirements.
We first turned our attention to the palladium source in an effort to replace the oxygen-
sensitive Pd2(dba)3 used in our original conditions. Therefore, the original catalytic 
enantioconvergent decarboxylative allylic alkylation of allyl 1-methyl-2-
oxocyclohexanecarboxylate (1a) was chosen as a model reaction (Scheme 1).[13]
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The catalytic cycle of the allylic alkylation operates starting from a zero valent palladium 
source and is believed to involve a palladium (0/II) redox cycle.[8]
While utilization of Pd2(dba)3 renders in situ reduction of the catalyst obsolete, its 
application is not only hampered by increased sensitivity to oxygen, but also the 
dibenzylideneacetone ligand is challenging to separate from non-polar reaction products.
In their original reports Tsuji and co-workers performed the allylic alkylation reactions in 
the presence of Pd(OAc)2 and PPh3.[4,5a] We adopted this strategy and started screening a 
variety of Pd(II) sources in combination with the chiral phosphinooxazoline ligands (S)-t-
BuPHOX 3 [14] and (S)-(CF3)3-t-BuPHOX 4 (Figure 1).[15]
When comparing Pd(OAc)2 and Pd2(dba)3 at 1.0 mol % palladium in combination with a 
tenfold excess of PHOX ligands 3 or 4 respectively, in TBME at 80 °C we were pleased to 
find that both palladium sources exhibited comparable catalytic performance (Table 1, 
entries 1–4). At lower palladium concentrations, however, Pd(OAc)2 was clearly superior, 
delivering quantitative yields and good enantioselectivity at only 0.10 mol % Pd (Table 1, 
entries 5 and 6). When 0.10 mol % Pd2(dba)3 was used to form the catalyst, a dramatic 
decrease in yields was observed (Table 1, entries 7 and 8).
We then became interested to see if other palladium(II) sources were equally suited to 
catalyze the decarboxylative allylic alkylation. Consequently, a total of eight different 
commercially available Pd(II) precursors were examined in our model reaction in the 
presence of ligand 3.[16] While with Pd(OAc)2 a quantitative yield for the desired allylic 
alkylation product was obtained, none of the other palladium(II) sources promoted any 
conversion of the substrate. We reason that the limited solubility of these palladium salts in 
TBME likely prevented catalysis.
Limited to Pd(OAc)2 as the only viable palladium precursor, we turned our attention to 
minimizing the catalyst loading. A screening of six different catalyst loadings, ranging from 
0.05 mol % to 1.0 mol %, was performed (Table 2). All reactions were conducted in the 
presence of a tenfold excess of ligand with respect to palladium, in TBME at 40 °C.[18]
Under these reaction conditions, palladium loadings as low as 0.10 mol % were sufficient to 
deliver the desired allylic alkylation product in 90% yield and with high enantioselectivity 
(Table 2, entry 5). To obtain a quantitative yield of ketone 2a, the catalyst loading was 
increased to 0.15 mol % of Pd(OAc)2 (Table 2, entry 4). Enantioselective allylic alkylation 
reactions are typically performed in solvents such as THF,[6,19] DCM,[19b,c] dioxane[2,20] or 
diethylether.[13] While these solvents are common for academic laboratory scale, their use 
prohibits conducting the reaction in an industrial setting.[21] We sought to overcome this 
limitation and performed a solvent screening with a total of ten different solvents that are 
considered to be safe, sustainable and cost-efficient (Table 3).[21,22]
Conversion of allyl 1-methyl-2-oxocyclohexane-carboxylate (1a) in TBME resulted in a 
high yield and good enantioselectivity (Table 3, entry 1). When the reaction was performed 
in various alkyl acetates the yields dropped dramatically, to 12%, 28% and 17% respectively 
(Table 3, entries 2, 4 and 5). Similarly low yields were observed for reactions performed in 
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acetonitrile, dimethylacetamide, 2-Me-THF, and acetone (Table 3, entries 3, 6, 8 and 10). 
Moderate conversion was found when the reaction was performed in toluene (Table 3, entry 
7). Consequently, all further experiments were carried out in TBME.
At this point, we considered that the palladium concentration could be lowered further by 
performing the reaction at higher temperatures, and we were interested in the influence of 
increased reaction temperature on stereoselectivity. All experiments were performed in 
TBME with a tenfold excess of ligand 3 (Table 4). A palladium loading as low as 0.075 mol 
% afforded ketone 2a in 99% yield when the reaction was performed at 80 °C, which 
corresponds to a turnover number of 1320 for the in situ formed catalyst. Nevertheless, a 
slightly lower enantioselectivity of 84% was observed in this case (Table 4, entry 1). At 60 
°C and 40 °C, palladium loadings of 0.10 and 0.125 mol % respectively were sufficient to 
deliver the desired product in quantitative yield and retain high enantioselectivity (Table 4, 
entries 2 and 3).
We then applied the protocol to the 10 and 20 mmol scale synthesis of alpha-quaternary 
ketones 2a and 2b (Table 5). Both reactions were performed in TBME with a tenfold excess 
of ligand 3. Cyclohexanone 1a was converted on a 10.0 mmol scale (1.96 g) in the presence 
of 0.15 mol % (3.37 mg) of Pd(OAc)2 at 60 °C. The corresponding product 2a was isolated 
by distillation in excellent yield and high enantioselectivity (Table 5, entry 1). Similarly, 
tetralone substrate 1b was subjected to enantioselective allylic alkylation conditions at 40 °C 
on a 20 mmol scale (4.89 g). The desired product 2b was purified by flash chromatography 
and isolated in 95% yield and 88% ee (Table 5, entry 2).
Satisfied with the scalability of our new allylic alkylation conditions, we turned our attention 
to reducing the ligand loading. A series of six experiments, employing different quantities of 
ligand, from 0.20 mol % to 1.0 mol %, in the presence of 0.10 mol % Pd(OAc)2 was 
performed (Table 6).
A ligand loading of 0.40 mol %, which corresponds to a 4-fold excess of ligand with respect 
to palladium, was sufficient to provide the desired product in quantitative yield and high 
enantioselectivity (Table 6, entry 4). Only at a loading of 0.20 mol % of ligand 3 a slight 
decrease in enantioselectivity was observed (Table 6, entry 5).
Finally, we investigated the influence of concentration on reactivity. A brief study across 
five different substrate concentrations was executed (Table 7).
We were pleased to find that the decarboxylative alkylation reaction could be performed in 
high concentrations of up to 0.40 M without any negative impact on yield or enantiomeric 
excess (Table 7, entry 1). When the reaction was performed at higher dilution (0.033 M) a 
slight decrease in yield and optical purity was observed (Table 7, entry 5).
After optimizing all critical reaction parameters for the conversion of cyclohexanone 
substrate 1a we sought to investigate the substrate scope of this novel protocol. In particular 
the decarboxylative allylic alkylation of lactams is important, given the prevalence of 
quaternary N-heterocycles in biologically active alkaloids and their potential importance in 
pharmaceutical agents.[23] Initial experiments suggested that higher palladium loadings were 
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required for the decarboxylative allylic alkylation of piperidinones. Consequently, a brief 
study was performed to determine the minimal palladium loading needed to efficiently 
catalyze the reaction (Table 8). The electron-poor ligand (S)-(CF3)3-t-BuPHOX 4 was 
applied in the presence of varying amounts of Pd(OAc)2 in TBME at 60 °C.[23]
At 0.10 mol % of Pd(OAc)2 the desired product was obtained in only 77% yield and a 
reduced enantioselectivity of 84% ee. (Table 8, entry 3) Nevertheless, a catalyst 
concentration of only 0.30 mol % was sufficient to render the chiral lactam 6a in 85% yield 
and 97% ee (Table 8, entry 2). Compared to the original report, in which 5.0 mol % of 
Pd2(dba)3 were applied, this constitutes a more than thirtyfold decrease in palladium 
loading.
To demonstrate the broad applicability of this novel protocol, a total of ten compounds were 
subjected to the improved reaction parameters (Table 9). Asymmetric allylic alkylation to 
generate products 2a, 2b and 6a was discussed previously in detail (Table 9, entries 1–3). 
Allylmethylpiperidinone 6b and allylfluoropiperidinone 6d were synthesized in a similar 
fashion. Yields of 81% and 80% respectively, and enantioselectivities of up to 99% could be 
obtained (Table 9, entry 4 and 6). In the latter case, a catalyst loading as low as 0.125 mol % 
was sufficient to yield the product in near to perfect enantioselectivity. Despite the 80-fold 
reduction in palladium loading compared to the original procedure, no erosion of 
enantioselectivity was observed (Table 9, entry 6).
Gratifyingly, the novel allylic alkylation protocol could be applied to seven-membered rings 
as well; however, despite a near quantitative yield only reduced enantiomeric excess of 70% 
was observed for ketone 2c (Table 9, entry 7). Nevertheless, seven-membered caprolactam 
6e was isolated in 95% yield and high enantioselectivity (Table 9, entry 8). Notably, despite 
the dilution, cyclohexylketal 2d was generated in 79% yield and good enantioselectivity 
through intermolecular allylic alkylation of the corresponding silyl enol ether and allyl 
methanesulfonate (Table 9, entry 9).
Finally, cyclohexanedione 2e, which is a critical intermediate in the synthesis of (−)-
cyanthiwigin F,[9b] could be accessed through double enantioselective allylic alkylation of 
the bis(β-ketoester) 1e in excellent yield and near perfect enantioselectivity using only 0.25 
mol % palladium. This corresponds to 5% of the palladium loading used in the original 
protocol. Despite the considerable reduction in catalyst concentration the yield for this 
reaction was improved to 97% (Table 9, entry 10).
In conclusion, we have reported a novel and highly efficient protocol for the decarboxylative 
enantioselective allylic alkylation using palladium acetate and loadings below 0.50 mol %. 
For simple quaternary ketone products metal loadings as low as 0.075 mol % effectively 
catalyzed the reaction and generated the desired products in high yields and 
enantioselectivities. Thereby, turnover numbers (TON) of up to 1320 could be reached. We 
envision that the key for high TON in this system involves the lack of dba in the reaction 
mixture, which would likely result in trapped Pd(0)-olefin species that lie outside of the 
catalytic cycle.[8b] Furthermore, a variety of critical reaction parameters such as 
temperature, concentration, ligand stoichiometry and choice of solvent were optimized to 
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increase the scalability and lower the cost basis for palladium-catalyzed allylic alkylation 
reactions. The method is broadly applicable among a variety of substrate classes for both 
inter- and intramolecular allylic alkylations, and is tolerant of most functional groups 
because of the neutral reaction conditions and modest reaction temperatures. We anticipate 
these advances will promote the continued use of palladium-catalyzed allylic alkylation 
reactions as means of installing quaternary stereocenters in multi-step syntheses in academic 
laboratories, and hope to see these reactions used to synthesize valuable molecules in the 
chemical and pharmaceutical industries.
Experimental Section
General Procedure
In a nitrogen-filled glove box, a stock solution of Pd(OAc)2 (1.1 mg, 4.9 μmol, in 20 mL 
TBME) was prepared in a 20 mL scintillation vial. In a separate 1-dram vial, (S)-t-BuPHOX 
(1.9 mg, 4.9 μmol) was dissolved in TBME (1 mL). To a 2-dram vial equipped with a 
magnetic stirbar, 1.02 mL of the Pd(OAc)2 solution was added (56 μg, 0.25 μmol, 0.125 mol 
%) followed by 0.51 mL of the (S)-t-BuPHOX solution (0.97 mg, 2.5 μmol, 1.25 mol %). 
This mixture was stirred at ambient temperature (28 °C) in the glove box for 30–40 min. 
Substrate (0.20 mmol, 1.0 equiv) was taken up in TBME (0.5 mL) and added to the stirring 
catalyst solution. In reactions analyzed by GC, tridecane (24 μL, 0.1 mmol, 0.5 equiv) was 
added. The reaction was sealed with a Teflon-lined cap, removed from the glove box and 
stirred at the indicated temperature for the indicated duration of time. At this point, the 
reaction was analyzed by GC, or passed through a silica plug, concentrated in vacuo, and 
purified by distillation or column chromatography.
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Figure 1. 
Chiral phosphinooxazoline ligands applied in this investigation.
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Scheme 1. 
Pd-catalyzed enantioconvergent de-carboxylative allylic alkylation.
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Table 2
Optimization of the Pd(OAc)2 loading for the decarboxylative allylic alkylation.
Entry Pd [mol %] 3 [mol %] Yield [%] a) ee [%] b)
1 1.00 10.0 99 90
2 0.50 5.0 99 90
3 0.25 2.50 99 90
4 0.15 1.50 99 89
5 0.10 1.0 90 89
6 0.05 0.50 10 89
a)GC yield relative to an internal standard (tridecane).
b)
Enantiomeric excess measured by chiral GC.[17]
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Table 3
Optimization of the reaction medium.
Entry solvent Yield [%] a) ee [%] b)
1 TBME 88 89
2 EtOAc 12 c) 74
3 Acetonitrile trace -
4 Isopropyl acetate 28 64
5 Isobutyl acetate 17 -
6 Dimethylacetamide trace -
7 Toluene 52 80
8 2-Me-THF 21 89
9 t-AmylOH
- 
c) -
10 Acetone 12 c) 47
a)GC yield relative to an internal standard (tridecane).
b)
Enantiomeric excess measured by chiral GC.
c)
Reaction performed at 60 °C.[17]
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Table 4
Optimization of the palladium loading for the decarboxylative allylic alkylation at various temperatures.
Entry Pd [mol %] T [°C] Yield [%] a) ee [%] b)
1 0.075 80 99 84
2 0.10 60 99 88
3 0.125 40 99 89
a)GC yield relative to an internal standard (tridecane).
b)
Enantiomeric excess measured by chiral GC.[17]
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Table 6
Optimization of the ligand loading for the decarboxylative allylic alkylation.
Entry Ligand 3 [mol %] Yield [%] a) ee [%] b)
1 1.00 99 88
2 0.80 99 89
3 0.60 99 88
4 0.40 99 88
5 0.20 99 86
a)GC yield relative to an internal standard (tridecane).
b)
Enantiomeric excess measured by chiral GC.[17]
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Table 7
Optimization of the reaction concentration.
Entry concentration [M] Yield [%] a) ee [%] b)
1 0.40 99 88
2 0.20 99 88
3 0.10 99 89
4 0.05 99 89
5 0.033 91 87
a)GC yield relative to an internal standard (tridecane)
b)
Enantiomeric excess measured by chiral GC.[17]
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Table 8
Optimization of the palladium loading for the decarboxylative allylic alkylation of lactams.
Entry Pd [mol %] 4 [mol %] Yield [%] a) ee [%] b)
1 0.50 5.0 87 96
2 0.30 3.0 85 97
3 0.10 1.0 77 84
a)GC yield relative to an internal standard (tridecane).
b)
Enantiomeric excess measured by HPLC.[17]
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